Decoding Biology for a Brighter Future: Recursion Secures $200M Funding Round
Recursion
Get the full Recursion company profile
Access contacts, investors, buying signals & more
Decoding biology just got a significant boost as Recursion recently announced raising an impressive $200,000,000 in funding.
The clinical-stage TechBio company is on a mission to revolutionize drug discovery by seamlessly integrating cutting-edge technologies in biology, chemistry, automation, data science, and engineering.
By industrializing the drug discovery process, Recursion aims to decode complex biology through innovative approaches.
With a vision to radically improve lives through biology, the company is committed to leveraging diverse expertise, backgrounds, and perspectives to drive its pioneering research forward.
Based in Salt Lake City, Recursion is at the forefront of decoding biology to unlock new possibilities in the field of biopharmaceuticals.
Buying Signals & Intent
Our AI suggests Recursion may be interested in:
Unlock GTM Signals
Discover Recursion's tech stack and active buying intent signals.
View GTM SignalsTrusted by 200+ sales professionals
Unlock Investor Data
See who invested in Recursion and connect with key investment contacts.
Unlock InvestorsTrusted by 200+ sales professionals
Unlock Key Decision-Makers
Get direct access to the key decision-makers at Recursion.
Unlock Decision-MakersTrusted by 200+ sales professionals
Similar Recently Funded Companies
No similar companies found